Method for screening the activity of expressed polypeptides
AssigneeProImmune Limited
InventorsNikolai SCHWABE, Sarah WILKINS
Life of this patent
Estimating the term…
Loading patent…
AssigneeProImmune Limited
InventorsNikolai SCHWABE, Sarah WILKINS
Estimating the term…
The present invention relates to a method for screening the activity of a polypeptide, and, equally, for producing a polypeptide with a desired activity by said screening, in an efficient and cost effective manner and with high sensitivity. The methods of the present invention comprise (i) expressing a polypeptide by cell-free in vitro translation and (ii) determining the activity of the expressed polypeptide by solution titration with an interaction member. The screening of a wild-type polypeptide and a mutant library derived there from can be used for identifying a activity of these polypeptides to an interaction member as a consequence of one or more point mutations. Furthermore, the present invention relates to methods for identifying polypeptides with therapeutically relevant properties as a consequence of the identified desired activity of a polypeptide from a mutant library.
A method for screening the activity of a polypeptide comprising (i) expressing a polypeptide by cell-free in vitro translation and (ii) determining the activity of the expressed polypeptide by solution titration with an interaction member.
A method for producing a polypeptide with a desired activity comprising (i) expressing a polypeptide by cell-free in vitro translation and (ii) determining the activity of the expressed polypeptide by solution titration with an interaction member.
21-26. (canceled)
Dependencies are inferred from the claim text.